Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07065747 · ClinicalTrials.gov registry record

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

A clinical trial of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA), sponsored by Oregon Health and Science University.

Recruiting
Registry status
125
Enrollment target
1
Study location

NCT07065747 is a study of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA) that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 125 participants, below the 2,164-participant average among 21 other Sarcoidosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07065747, a study of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA), is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
125 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.

Study Locations (1)

Oregon

  • Casey Eye Institute - Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2024-09-01
Est. Completion 2026-12

What the Registry Record Tells You About NCT07065747

The ClinicalTrials.gov registry entry for NCT07065747 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,164-participant average among 21 other Sarcoidosis trials with a reported enrollment target (94% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Sarcoidosis appearing as the primary indexed condition, and to 0 interventions.

NCT07065747 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT07065747 about?

NCT07065747 is a clinical study titled "Quantification & Classification of Inflammatory Cells in Uveitis Using OCT". The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. An...

What is the current status of trial NCT07065747?

This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2024-09-01. Estimated completion is 2026-12.

What conditions does trial NCT07065747 study?

This clinical trial studies the following conditions: Sarcoidosis, Juvenile Idiopathic Arthritis (JIA), Birdshot Chorioretinitis, Behcet Disease, Posterior Vitreous Detachment.

Who is sponsoring clinical trial NCT07065747?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07065747 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcoidosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.